Financial Performance Summary - Full year net sales were up by 1.4% reaching $1,692.1 million compared to $1,668.3 million in the prior year[23] - Adjusted EBITDA for the full year declined by 12.3% to $396.8 million[23, 24] - Diluted adjusted EPS decreased by 34% to $3.94[23, 118] Segment Performance - Performance Materials' full year sales increased by 6.8% to $586.0 million[12] and segment EBITDA increased by 13.6% to $286.6 million[12] - Road Technologies' full year sales increased by over 53% due to increased technology adoption and the acquisition of Ozark road markings business, reaching $369.8 million[17, 31] - Advanced Polymer Technologies' full year sales decreased by 16.6% to $204.0 million[28] - Industrial Specialties' full year sales decreased by 16% to $532.3 million[31, 43] 2024 Guidance - The company expects revenue between $1.40 billion and $1.55 billion[19] - Adjusted EBITDA is projected to be between $365 million and $390 million[19] - Capital expenditures are estimated to be between $90 million and $110 million[19]

Exhibit 99.1 News Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Contact: Caroline Monahan 843-740-2068 media@ingevity.com Investors: John Nypaver 843-740-2002 investors@ingevity.com Ingevity reports fourth quarter and full year 2023 financial results Fourth Quarter (comparisons versus prior year period): Full Year (comparisons versus prior year period): Guidance: Company announces full year 2024 guidance for sales between $1.40 billion and $1.55 billion an ...

Financial Performance - Net sales decreased by 7.5% to $446.0 million in Q3 2023 compared to $482.0 million in Q3 2022 [31] - Adjusted EBITDA decreased by 20.1% to $110.4 million with a margin of 24.8% in Q3 2023, compared to $138.2 million with a margin of 28.7% in Q3 2022 [31] - Diluted adjusted EPS decreased by 42.1% to $1.21 in Q3 2023, compared to $2.09 in Q3 2022 [31] - Performance Chemicals segment EBITDA decreased by 62% due to higher CTO costs and weak demand, reaching $24.7 million with a margin of 9.6% [4, 53, 59] Segment Performance - Performance Materials net sales increased by 1.6% to $147.2 million, with segment EBITDA up by 21.7% to $74.5 million and a margin of 50.6% [45] - Industrial Specialties sales decreased by 30% due to lower volumes, with segment EBITDA flat at $11.2 million and a margin of 26.2% [14, 42] - Pavement Technologies sales increased by 47% due to pricing gains and the Ozark acquisition [61] - Advanced Polymer Technologies (APT) sales decreased by 4% to $256.0 million due to lower volumes, with segment EBITDA margin improving to 26.2% [13, 14] Strategic Initiatives and Outlook - The company is repositioning its Performance Chemicals business to focus on higher margin specialty products, expecting EBITDA margins to improve from mid-single digits to 15-20% [30, 50] - The company expects approximately $180 million of non-cash charges and $100 million in cash charges related to the repositioning, with the majority of non-cash and 50-60% of cash charges recognized by the end of the first half of 2024 [8, 70] - The company anticipates ~$25 million in combined savings from Q2 actions and the repositioning announcement [48] - The company reduced total global headcount by approximately 20% [17] - The company expects revenue between $1.6 and $1.7 billion, adjusted EBITDA between $375 and $390 million, capital expenditures between $95 and $105 million, and free cash flow between $75 and $85 million for the full year [47]

_______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 __________________________________________________________________________ INGEVITY CORPOR ...

Free cash flow impacted by expected cash spend related to WestRock plant closure and cost reduction actions totaling approximately $30 million (1) Please see appendix for Ingevity's use of non-GAAP financial measures, definitions of those financial measures and reconciliations to the nearest GAAP financial measures. 10 FOR MORE INFORMATION Media Caroline Monahan (843) 740 - 2068 11 Investors John E. Nypaver, Jr. (843) 740 - 2002 Thank you for your interest in Ingevity. APPENDIX 『ingevity 12 Ingevity has pre ...

Ingevity Corporation (NYSE:NGVT). Q2 2023 Earnings Conference Call August 3, 2023 10:00 AM ET Company Participants John Nypaver - Vice President, Investor Relations and Treasurer John Fortson - President and CEO Mary Hall - Chief Financial Officer Ed Woodcock - President, Performance Materials Rich White - President, Performance Chemicals Conference Call Participants Vincent Anderson - Stifel John McNulty - BMO Capital Markets Jon Tanwanteng - CJS Securities Ian Zaffino - Oppenheimer Daniel Rizzo - Jefferie ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 _______________________ ...

Provision (benefit) for Income Taxes on Adjusted earnings (loss) is defined as provision for income taxes plus the tax expense (benefit) on restructuring and other (income) charges, net, acquisition and otherrelated costs, debt refinancing fees, litigation verdict charges, (losses) and gains from the sale of strategic investments, pension and postretirement settlement and curtailment (income) charges, less the provision (benefit) from certain discrete tax items. Net Debt Ratio is defined as Net Debt divided ...

Ingevity Corporation (NYSE:NGVT) Q1 2023 Earnings Conference Call May 4, 2023 10:00 AM ET Company Participants John Nypaver - VP, IR & Treasurer John Fortson - President, CEO & Director Mary Hall - EVP & CFO Richard White - SVP & President, Performance Chemicals Steve Hulme - SVP & President, Advanced Polymer Technologies Stuart Woodcock - EVP & President, Performance Materials Conference Call Participants Vincent Anderson - Stifel, Nicolaus & Company Jonathan Tanwanteng - CJS Securities Christopher Kapsch ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _______________________________________________________________________ FORM 10-Q _______________________________________________________________________ ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37586 ______________________ ...